Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure

Author(s):
Mookerjee, R.P.; Pavesi, M.; Thomsen, K.L.; Mehta, G.; Macnaughtan, J.; Bendtsen, F.; Coenraad, M.; Sperl, J.; Gines, P.; Moreau, R.; Arroyo, V.; Jalan, R.; CANONIC Study Investigatos
Published
2016
Publication type
Article / Letter to editor
Acute-on-chronic liver failureCirrhosisMulti-organ failureSepsisPrognosisNon-selective beta blockers
Date issued
2016-03-31
Language
English
Is part of
Journal of Hepatology (2016), Vol. 64, no. 3, p. 574-582
hdl
1887/117452